why choose us

First received: June 04, 2024

Clinical Trial: PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Tumor Regression Grade

Study Type: OBSERVATIONAL


Official Title: PPIO-009 Tumor Regression Grade and Prognosis Analysis of Esophageal Cancer in Different Tumor Location After Neoadjuvant Immunotherapy

Brief Summary: At present, the evaluation of the effect of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophageal cancer is mainly based on postoperative pathology, among which, the pathological assessment of tumor regression grade (TRG) and TNM staging are the basis for the routine pathological diagnosis of esophageal cancer, and the College of American Pathologists divides the TRG after neoadjuvant therapy to esophageal cancer into four grades: 0, 1, 2, and 3.The residual primary tumor in the…

Read more